Erythropoietin pretreatment suppresses inflammation by activating the PI3K/Akt signaling pathway in myocardial ischemia-reperfusion injury

Experimental and Therapeutic Medicine

Volumn 10, Issue 2, 2015, Pages 413-418

  Rong, Ren ^a   Xijun, Xiao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Erythropoietin; Myocardial ischemia reperfusion injury; Phosphoinositide 3 kinase protein kinase B

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P85; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; INFLAMMATION; MALE; NECROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84931838113     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2534     Document Type: Article

References (24)

1. Chen K, Li G, Geng F, et al: Berberine reduces ischemia/reperfusion-induced myocardial apoptosis via activating AMPK and PI3K-Akt signaling in diabetic rats. Apoptosis 19: 946-957, 2014.
2. Yan X, Qiu W, Jia B, et al: Myocardial protection by interferon-γ late preconditioning during cardiopulmonary bypass-associated myocardial ischemia-reperfusion in pigs. Oncol Rep 30: 2145-2152, 2013.
3. Lassaletta AD, Elmadhun NY, Zanetti AV, et al: Rapamycin treatment of healthy pigs subjected to acute myocardial ischemia-reperfusion injury attenuates cardiac functions and increases myocardial necrosis. Ann Thorac Surg 97: 901-907, 2014.
4. Du X, Hu X and Wei J: Anti-inflammatory effect of exendin-4 postconditioning during myocardial ischemia and reperfusion. Mol Biol Rep 41: 3853-3857, 2014.
5. Kim HJ, Joe Y, Kong JS, et al: Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3beta. Oxid Med Cell Longev 2013: 306-421, 2013.
6. Hofmann BT and Jücker M: Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85α regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Cell Signal 24: 1950-1954, 2012.
7. Chen L, Wei X, Hou Y, Liu X, et al: Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats. Neurochem Int 66: 27-32, 2014.
8. Palis J: Primitive and definitive erythropoiesis in mammals. Front Physiol 5: 3, 2014.
9. Jelkmann W: Physiology and pharmacology of erythropoietin. Transfus Med Hemother 40: 302-309, 2013.
10. Yang C, Zhao T, Lin M, et al: Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model. Exp Biol Med (Maywood) 238: 111-119, 2013.
11. Zhang Q, Bian H, Li Y, Guo L, Tang Y and Zhu H: Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent neuroprotection against cerebral ischemia in rats. J Ethnopharmacol 154: 443-452, 2014.
12. Liu X, Xie W, Liu P, et al: Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion. Life Sci 78: 2255-2264, 2006.
13. Meij JT, Sheikh F, Jimenez SK, et al: Exacerbation of myocardial injury in transgenic mice overexpressing FGF-2 is T cell dependent. Am J Physiol Heart Circ Physiol 282: H547-H555, 2002.
14. Zhang S, Lv JW, Yang P, et al: Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. Am J Pathol 181: 937-946, 2012.
15. Liu H, Guo X, Chu Y and Lu S: Heart protective effects and mechanism of quercetin preconditioning on anti-myocardial ischemia reperfusion (IR) injuries in rats. Genes 545: 149-155, 2014.
16. Jia Y, Mo SJ, Feng QQ, et al: EPO-Dependent activation of PI3K/AKT/FOXO3a signalling mediates neuroprotection in in vitro and in vivo models of Parkinson's disease. J Mol Neurosci 53: 117-124, 2014.
17. Jun JH, Jun NH, Shim JK, Shin EJ and Kwak YL: Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia. Eur J Pharmacol 745: 1-9, 2014.
18. Lu MJ, Chen YS, Huang HS and Ma MC: Erythropoietin alleviates post-ischemic injury of rat hearts by attenuating nitrosative stress. Life Sci 90: 776-784, 2012.
19. He W, Wang Z, Zhou Z, et al: Lipopolysaccharide enhances Wnt5a expression through toll-like receptor 4, myeloid differentiating factor 88, phosphatidylinositol 3-OH kinase/AKT and nuclear factor kappa B pathways in human dental pulp stem cells. J Endod 40: 69-75, 2014.
20. Zhang J, Yao Y, Xiao F, et al: Administration of dexamethasone protects mice against ichemia/reperfusion induced renal injury by suppressing PI3K/AKT signaling. Int J Clin Exp Pathol 6: 2366-2375, 2013.
21. Wang J, Li L and Jiang H: C-Cbl inhbition: A novel therapeutic approach for attenuating myocardial ischemia and reperfusion injury. Int J Cardiol 186: 50-51, 2015.
22. Lin Y, Chen L, Li W and Fang J: Role of high-mobility group box-1 in myocardial ichemia/reperfusion injury and the effect of ethyl pyruvate. Exp Ther Med 9: 1537-1541, 2015.
23. Yao HC, Yang LJ, Han QF, et al: Postconditioning with simvastatin decreases myocardial injury in rats following acute myocardial ischemia. Exp Ther Med 9: 1166-1170, 2015.
24. Rafiee P, Shi Y, Su J, et al: Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways. Basic Res Cardiol 100: 187-197, 2005.